The data items required for National Cancer Data Standards for Wales – Site Specific - Upper Gastrointestinal (GI) and their equivalent labels in COSD V9.0, where there is an equivalent, are listed below.
Where the specification cites NHS Wales Data Dictionary, please refer to the Dictionary for the relevant guidance i.e. definition, format, or code list.
For consistency, all dates listed in the Specification are standardised as ccyymmdd.
Where D is denoted in Status, this indicates that the information should be derived from another data item. This typically occurs with data items that are simply text representations of their code counterparts. Other Status codes are M (Mandatory), R (Required) – the data item should be recorded where applicable and O (Optional).
Core data items should be collected for all cancers. To reduce replication of information, Core data items have not been listed in this site-specific Standard and users should refer to National Cancer Data Standards for Wales – Core (1. National Cancer Data Set - Full list DSCNs.xlsx (live.com)) for a list of Core requirements. However, in some cases, the site-specific application of Core data items may differ e.g. a particular tumour site may require additional or fewer codes to those already published in Core, or perhaps have additional business rules as to how the Core data item should be coded. Where this occurs, the Core data item will be replicated in the site-specific Standard with the respective additional site-specific detail. These are flagged in the following table with an * next to the data item name.
For data items used in the National Cancer Data Standards for Wales that already exist within the NHS Wales Data Dictionary. These data items have been flagged with an † next to the data item name, as whilst this introduces a change to an existing information standard, the immediate use of this mandate will be used as a framework for the development of the CIS, therefore service/data providers should continue with ‘business as usual’ in terms of the data being collected and reported.
National Cancer Data Standards for Wales – Upper Gastrointestinal (GI): Oesophago-gastric (OG)
Reporting Data Item |
Definition |
Format |
Code List (Code) |
Code List (Text) |
Status |
COSD |
Referral - Oesophago-gastric (OG). To carry referral details for OG (One occurrence of this group) | ||||||
Source of Referral for Out-patients (CWT) * |
The source of referral
classification used to identify the source of referral of each episode or
referral |
Code List |
20 |
Open Access Endoscopy |
R |
Source of Referral for Out-patients (CWT) (CR1600) |
21 |
From Barrett's Surveillance | |||||
99 |
Not Known | |||||
Diagnosis - Oesophago-gastric (OG). To carry diagnosis details for OG (One occurrence of this group) | ||||||
Pre-Treatment Tumour Site |
Specify the characteristics
of the OG cancer at diagnosis |
Code List |
01 |
Oesophagus upper third |
D |
N/A |
02 |
Oesophagus middle third | |||||
03 |
Oesophagus lower third | |||||
04 |
Siewert 1 | |||||
05 |
Siewert 2 | |||||
06 |
Siewert 3 | |||||
07 |
Fundus | |||||
08 |
Body of stomach | |||||
09 |
Antrum | |||||
10 |
Pylorus | |||||
Staging Procedures |
Record the investigations performed to establish the stage of disease |
Code List |
00 |
None |
R |
N/A |
01 |
CT Scan | |||||
02 |
PET/PET-CT | |||||
03 |
Endoscopic US/EUS | |||||
04 |
Staging laparoscopy | |||||
05 |
EUS Fine needle aspiration | |||||
97 |
Other | |||||
Comorbidity |
Specify what other long term
conditions the patient has at diagnosis. To detail the
nature of any pre-existing conditions/co-morbidity which may have an
effect on subsequent treatment. |
Code List |
00 |
None |
R |
N/A |
01 |
COPD/Asthma | |||||
02 |
Chronic Renal Impairment | |||||
03 |
Liver Failure or Cirrhosis | |||||
04 |
Diabetes | |||||
05 |
Mental Illness | |||||
06 |
Barrett’s Oesophagus | |||||
97 |
Significant Other | |||||
07 |
Ischemic Heart Disease | |||||
08 |
Cerebrovascular Disease | |||||
09 |
Peripheral Vascular Disease | |||||
Dietetic Involvement Before Treatment |
Specify what type of dietetic involvement (or planned involvement) the patient will receive between diagnosis and treatment. |
Code List |
1 |
Assessment and advice from a general dietitian |
R |
N/A |
2 |
Assessment and advice from a specialist OG dietitian | |||||
3 |
Assessment and advice from a dietitian not known if general or specialist | |||||
4 |
No contact with a dietitian as no dietitian available | |||||
5 |
No contact with a dietitian as assessed as not required | |||||
6 |
No contact with a dietitian | |||||
Investigations - Oesophago-gastric (OG). To carry staging investigations details for OG (One occurrence of this group) | ||||||
Staging Procedures |
Indicate the staging
investigations performed in order to establish the cancer
stage |
Code List |
00 |
None |
R |
N/A |
01 |
CT Scan | |||||
02 |
PET/PET-CT | |||||
03 |
Endoscopic US/EUS | |||||
04 |
Staging laparoscopy | |||||
05 |
EUS Fine needle aspiration | |||||
97 |
Other | |||||
Cancer Care Plan - Oesophago-gastric (OG). To carry details of the cancer care plan for OG (One occurrence of this group) | ||||||
Planned Cancer Treatment
|
This is the clinically
proposed treatment, |
Code List |
01 |
Surgery |
R |
Cancer Treatment Modality CR2040 |
02 |
Teletherapy | |||||
03 |
Chemotherapy | |||||
15 |
Endoscopic Mucosal Resection | |||||
14 |
Radiotherapy - Other | |||||
16 |
Palliative surgery | |||||
17 |
Palliative oncology: Unspecified | |||||
18 |
Endoscopic palliative therapy: Unspecified | |||||
07 |
Biological Therapy | |||||
Surgery - General - Oesophago-gastric (OG). To carry surgery details for OG (One occurrence per Core Surgery and Other Procedure group) | ||||||
Palliative Treatment Reason
|
Rationale for palliative treatment |
Code List |
1 |
Extensive intrahepatic disease |
M |
Palliative Treatment Reason
|
2 |
Widespread disease | |||||
3 |
Both extensive intrahepatic and widespread disease | |||||
4 |
Biliary obstruction | |||||
5 |
Gastric outlet obstruction | |||||
6 |
Pain | |||||
Surgical Admission Date |
The date of admission for the hospital stay during which the main surgical procedure took place |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Surgical Pathway Type |
Record the type of surgical pathway that the patient followed |
Code List |
1 |
A protocol enhanced recovery (ERAS) without daily documentation in medical notes |
R |
N/A |
2 |
A protocol enhanced recovery (ERAS) with daily documentation in medical notes | |||||
3 |
A standard surgical pathway | |||||
9 |
Not Known | |||||
ERAS Pathway Completed |
Did the patient complete the
ERAS pathway |
Code List |
1 |
Yes |
R |
N/A |
2 |
No, but partial completion | |||||
3 |
No, non-completion | |||||
9 |
Unknown/Not documented | |||||
Post Operative Tumour Site (Upper GI) |
The main cancer site for
which the patient is receiving care, as established in the resected
specimen. |
Code List |
01 |
Oesophagus upper third |
R |
Post Operative Tumour Site (Upper GI) (UG14230) |
02 |
Oesophagus middle third | |||||
03 |
Oesophagus lower third | |||||
04 |
Siewert 1 | |||||
05 |
Siewert 2 | |||||
06 |
Siewert 3 | |||||
07 |
Fundus | |||||
08 |
Body of stomach | |||||
09 |
Antrum | |||||
10 |
Pylorus | |||||
Main Procedure |
The main surgical procedure
carried out |
Code List |
01 |
Left Thoraco-abdominal Oesophagectomy |
D |
N/A |
02 |
2-Phase (Ivor-Lewis) Oesophagectomy | |||||
03 |
3-Phase (McKeown) Oesophagectomy | |||||
04 |
Transhiatal Oesophagectomy | |||||
05 |
Thoracotomy (Open & Shut) | |||||
06 |
Total Gastrectomy | |||||
07 |
Extended Total Gastrectomy | |||||
08 |
Proximal Gastrectomy | |||||
09 |
Distal Gastrectomy | |||||
10 |
Completion Gastrectomy | |||||
11 |
Merendino Gastrectomy | |||||
12 |
Wedge/localised gastric resection | |||||
13 |
Bypass procedure/Jejunostomy only | |||||
14 |
Laparotomy (Open and Shut) | |||||
Surgical Access Thoracic * |
Record the approach used to
perform the thoracic part of the main procedure |
Code List |
01 |
Open Surgery |
R |
Surgical Access Type (CR6310) |
2a |
Thoracoscopic with planned conversion to open surgery | |||||
2b |
Thoracoscopic with unplanned conversion to open surgery | |||||
04 |
Thoracoscopic completed | |||||
5a |
Robotic converted to open | |||||
5b |
Robotic completed | |||||
Z |
Not applicable | |||||
Surgical Access Abdominal * |
Record the approach used to perform the abdominal
part of the main procedure |
Code List |
01 |
Open surgery |
R |
Surgical Access Type (CR6310) |
03 |
Laparoscopic with unplanned conversion to open surgery | |||||
04 |
Laparoscopic completed | |||||
5a |
Robotic converted to open | |||||
5b |
Robotic completed | |||||
Nodal Dissection |
Record the extent of the lymphadenectomy performed |
Code List |
0 |
None |
R |
N/A |
1 |
1-field | |||||
2 |
2-field | |||||
3 |
3-field | |||||
4 |
DO (peri-gut resection) | |||||
5 |
D1 | |||||
6 |
D2 | |||||
7 |
D3 | |||||
Discharge Date |
The date the patient was discharged or died in hospital |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Death in Hospital |
Indicates whether the patient died in hospital following surgical treatment. To monitor the proportion of deaths for surgically treated patients. |
Code List |
Y |
Yes |
R |
N/A |
N |
No | |||||
Post Operative Nutritional Support During Admission |
Record the type of nutritional support/intervention the patient receives during their admission for surgery |
Code List |
1 |
Nasojejunal tube |
R |
N/A |
2 |
Jejunostomy | |||||
3 |
Oral Nutrition | |||||
4 |
Parenteral Nutrition | |||||
7 |
Other | |||||
9 |
No Management | |||||
Dietetic Involvement After Surgery |
Record the type of dietetic involvement that the patient received after surgery |
Code List |
1 |
Assessment and advice from a general dietitian |
R |
N/A |
2 |
Assessment and advice from a specialist OG dietitian | |||||
3 |
Assessment and advice from a dietitian not known if general or specialist | |||||
4 |
No contact with a dietitian as no dietitial available | |||||
5 |
No contact with a dietitian as assessed as not required | |||||
6 |
No contact with a dietitian | |||||
Post Operative Nutritional Support on Discharge |
Record the type of ongoing nutritional support that the patient receives after surgery |
Code List |
1 |
Nasojejunal tube |
R |
N/A |
2 |
Jejunostomy | |||||
3 |
Oral Nutrition | |||||
4 |
Parenteral Nutrition | |||||
7 |
Other | |||||
9 |
No Management | |||||
No of Surgeons Involved in Original Operation |
Record the number of
surgeons involved in the original surgery.
|
max n1 |
N/A |
N/A |
R |
N/A |
Consultant Code of Surgeon Responsible for Original Operation |
Record the Consultant Code
of the surgeon responsible for the original operation |
an8 |
N/A |
N/A |
R |
N/A |
Consultant Code of any Additional Surgeons involved |
Record the Consultant Codes
of any additional surgeons that were involved in the original
operation |
an8 |
N/A |
N/A |
R |
N/A |
Surgery - Upper Gastrointestinal (GI). To carry additional surgery details for Upper GI - Esophageal Database (ESODATA) (One occurrence per Core surgery group) | ||||||
Surgical Complications -
International |
The types of complications
as defined in the International Esophageal Database (ESODATA). |
Code List |
0100 |
Gastrointestinal |
R |
Surgical Complications - International |
0101 |
No post-operative complications | |||||
0102 |
Oesophagoentric leak from anastomosis, staple line, or localised conduit necrosis | |||||
0103 |
Conduit necrosis/failure requiring surgery | |||||
0104 |
Ileus defined as small bowel dysfunction preventing or delaying enteral feeding | |||||
0105 |
Small bowel obstruction | |||||
0106 |
Feeding J-tube complication | |||||
0107 |
Pyloromyotomy/Pyloroplasty complication | |||||
0108 |
Clostridium Difficile infection | |||||
0109 |
GI bleeding requiring intervention or transfusion | |||||
0110 |
Pancreatitis | |||||
0111 |
Liver dysfunction | |||||
0112 |
Delayed conduit emptying requiring intervention or delaying discharge or requiring maintenance of ng drainage >7 days post op | |||||
0113 |
Bowel ischaemia | |||||
0199 |
None | |||||
0200 |
Pulmonary | |||||
0201 |
Pneumonia | |||||
0202 |
Pleural effusion requiring additional drainage procedure | |||||
0203 |
Pneumothorax requiring intervention | |||||
0204 |
Atelectasis mucous plugging requiring bronchoscopy | |||||
0205 |
Respiratory failure requiring intubation | |||||
0206 |
Acute respiratory distress syndrome | |||||
0207 |
Acute aspiration | |||||
0208 |
Tracheobronchial injury | |||||
0209 |
Chest drain requirement for air leak for >10 days post op | |||||
0299 |
None | |||||
0300 |
Cardiac | |||||
0301 |
Cardiac arrest requiring CPR | |||||
0302 |
Myocardial infarction | |||||
0303 |
Dysrhythmia atrial requiring intervention | |||||
0304 |
Dysrhythmia ventricular requiring intervention | |||||
0305 |
Congestive heart failure requiring intervention | |||||
0306 |
Pericarditis requiring intervention | |||||
0399 |
None | |||||
0400 |
Thromboembolic | |||||
0401 |
DVT (Deep Vein Thrombosis) | |||||
0402 |
PE (Pulmonary Embolus) | |||||
0403 |
Stroke (CVA) | |||||
0404 |
Peripheral thrombophlebitis | |||||
0499 |
None | |||||
0500 |
Urologic | |||||
0501 |
Acute renal insufficiency (defined as: doubling of baseline creatinine) | |||||
0502 |
Acute renal failure requiring dialysis | |||||
0503 |
Urinary tract infection | |||||
0504 |
Urinary retention requiring reinsertion of urinary catheter, delaying discharge, or discharge with urinary catheter | |||||
0599 |
None | |||||
0600 |
Infection | |||||
0601 |
Wound infection requiring opening wound or antibiotics | |||||
0602 |
Central iv line infection requiring removal or antibiotics | |||||
0603 |
Intrathoracic/Intra-abdominal abscess | |||||
0604 |
Generalised sepsis | |||||
0605 |
Other infections requiring antibiotics | |||||
0699 |
None | |||||
0700 |
Neurologic/Psychiatric | |||||
0701 |
Recurrent nerve injury | |||||
0702 |
Other neurologic injury | |||||
0703 |
Acute delirium | |||||
0704 |
Delirium tremens | |||||
0799 |
None | |||||
0800 |
Wound/Diaphragm | |||||
0801 |
Thoracic wound dehiscence | |||||
0802 |
Acute abdominal wall dehiscence/hernia | |||||
0803 |
Acute diaphragmatic hernia | |||||
0899 |
None | |||||
0900 |
Other | |||||
0901 |
Chyle leak | |||||
0902 |
Chyle leak severity/type | |||||
0903 |
Reoperation for thoracic bleeding | |||||
0904 |
Reoperation for abdominal bleeding | |||||
0905 |
Reoperation for reasons other than bleeding, anastomotic leak or conduit necrosis | |||||
0906 |
Multiple organ dysfunction syndrome | |||||
0950 |
Haemorrhage | |||||
0999 |
None | |||||
1000 |
Additional comments | |||||
1001 |
The patient had other complications that is not in the ECCG recommended complications list above | |||||
Leak Severity Type |
Record the severity of the
leak. |
Code List |
1 |
Type I |
R |
Leak Severity Type (UG15020) |
2 |
Type II | |||||
3 |
Type III | |||||
9 |
Not known (not recorded) | |||||
Conduit Necrosis/Failure Type |
Record the conduit
necrosis/failure type |
Code List |
1 |
Type I |
R |
Conduit Necrosis/Failure Type (UG15030) |
2 |
Type II | |||||
3 |
Type III | |||||
9 |
Not known (not recorded) | |||||
Recurrent Laryngeal Nerve Injury Involvement Type |
Record any recurrent
laryngeal nerve injury involvement type |
Code List |
1 |
Type Ia |
R |
Recurrent Laryngeal Nerve Injury Involvement Type (UG15040) |
2 |
Type Ib | |||||
3 |
Type IIa | |||||
4 |
Type IIb | |||||
5 |
Type IIIa | |||||
6 |
Type IIIb | |||||
9 |
Not known (not recorded) | |||||
Chyle Leak Severity Type |
Record any Chyle leak
severity type |
Code List |
1 |
Type Ia |
R |
Chyle Leak Severity Type (UG15050) |
2 |
Type Ib | |||||
3 |
Type IIa | |||||
4 |
Type IIb | |||||
5 |
Type IIIa | |||||
6 |
Type IIIb | |||||
9 |
Not known (not recorded) | |||||
Clavien-Dindo Classification of Surgical Classifications |
Record the overall grade as per the Clavien-Dindo Classification of Surgical Classifications |
Code List |
1 |
Grade I |
R |
Clavien-Dindo Classification of Surgical Classifications (UG15060) |
2 |
Grade II | |||||
3 |
Grade IIIa | |||||
4 |
Grade IIIb | |||||
5 |
Grade IVa | |||||
6 |
Grade IVb | |||||
7 |
Grade V | |||||
9 |
Not known (not recorded) | |||||
Additional Complications |
Did the patient have any
complications that is not in the ECCG recommended complication list
above? |
max an150 |
N/A |
N/A |
R |
Additional Complications (UG15070) |
Surgery - Upper Gastrointestinal (GI) - Outcome Measures. To carry additional surgery details for Upper GI - Eosophageal Database (ESODATA) (May be up to one occurrence per Core surgery group) | ||||||
Change in Level of Care |
Record if there was any change in the level of care required for the patient? |
Code List |
1 |
No escalation in level of care required |
R |
Change in Level of Care (UG15110) |
2 |
Required escalation in level of care (ICU, ITU/HDU) | |||||
9 |
Not Known (Not recorded) | |||||
Blood Product Utilisation |
Record if there were any blood products required? |
Code List |
1 |
Intra-operative transfusions |
R |
Blood Product Utilisation (UG15120) |
2 |
Post-operative transfusions | |||||
3 |
Intra and post op transfusions | |||||
8 |
Not Applicable (None - no transfusions) | |||||
9 |
Not known (not recorded) | |||||
Number of Units Transfused |
Record the number of units of blood transfused |
Code List |
1 |
1-2 Units |
R |
Number of Units Transfused (UG15130) |
2 |
3-4 Units | |||||
3 |
5 or more Units | |||||
9 |
Not Known (Not recorded) | |||||
Upper Gastrointestinal (GI) - Surgery - Oesophagectomy. To carry additional surgery details for - Oesophagectomy (One occurrence per Core surgery group) | ||||||
Surgical Approach Type |
Record the type of surgical approach used during the Oesophagectomy |
Code List |
1 |
Open Oesophagectomy |
R |
Surgical Approach Type (UG15200) |
2 |
Minimally Invasive Oesophagectomy | |||||
9 |
Not Known (Not recorded) | |||||
Open Approach Type |
Record the type of open surgical approach used during the Oesophagectomy |
Code List |
1 |
Trans Thoracic Oesophagectomy |
R |
Open Approach Type (UG15210) |
2 |
Trans Hiatal Oesophagectomy | |||||
Minimally Invasive Approach Type |
Record the type of minimally invasive approach used during the Oesophagectomy |
Code List |
1 |
Total Minimally Invasive |
R |
Minimally Invasive Approach Type (UG15220) |
2 |
Abdominal part minimally invasive | |||||
3 |
Chest part minimally invasive | |||||
Anastomosis Type |
Record the type of anastomosis used during the Oesophagectomy |
Code List |
1 |
Neck anastomosis |
R |
Anastomosis Type (UG15230) |
2 |
Chest anastomosis | |||||
3 |
None | |||||
8 |
Other | |||||
9 |
Not known (not recorded) | |||||
Oesophageal Conduit Type |
Record the type of oesophageal conduit used during the Oesophagectomy |
Code List |
1 |
Stomach |
R |
Oesophageal Conduit Type (UG15240) |
2 |
Small bowel | |||||
3 |
Colon | |||||
4 |
None | |||||
5 |
Other | |||||
9 |
Not known (not recorded) | |||||
Neck Dissection |
Record if there was any neck dissection during the Oesophagectomy |
Code List |
Y |
Neck dissection |
R |
Neck Dissection (UG15250) |
N |
No neck dissection | |||||
9 |
Not known (not recorded) | |||||
Surgery - Oesophago-gastric (OG) - Endocsopic or Radiological Procedures (One occurrence per Core Surgery ) | ||||||
Planned Course of Multiple Treatments |
Record if the first procedure is part of a planned course of multiple endoscopic treatments |
Code List |
Y |
Yes |
R |
N/A |
N |
No | |||||
9 |
Not Known | |||||
Endoscopic Procedure Type |
The main endoscopic
procedures carried out. |
Code List |
1 |
Stent insertion |
M |
Endoscopic Procedure Type (UG14290) |
2 |
Laser therapy | |||||
3 |
Argon plasma coagulation | |||||
4 |
Photodynamic therapy | |||||
5 |
Gastrostomy | |||||
6 |
Brachytherapy | |||||
7 |
Dilation | |||||
8 |
Other | |||||
9 |
ESD - Endoscopic Submucosal Dissection | |||||
10 |
EMR - Endoscopic Mucosal Resection | |||||
Stent Placement |
Record the method used to
place the stent |
Code List |
1 |
Fluroscopic control |
M |
N/A |
2 |
Endoscopic control | |||||
3 |
Fluroscopic and Endoscopic control | |||||
9 |
Not known | |||||
Anaesthesia Used |
Record the type of anaesthetic used during the procedure |
Code List |
1 |
Sedation |
M |
N/A |
2 |
Local anaesthetic spray | |||||
3 |
General anaesthetic | |||||
4 |
Sedation and local anaesthetic spray combined | |||||
9 |
Not Known | |||||
Endoscopic or Radiological Complication Type |
The types of complications
that the patient experiences during the admission for the endoscopic
procedure. |
Code List |
00 |
No complications |
M |
Endoscopic or Radiological Complication Type (UG13090) |
02 |
Perforation | |||||
03 |
Haemorrhage | |||||
09 |
Pancreatitis | |||||
10 |
Cholangitis | |||||
88 |
Other | |||||
Pathology - For Oesophago-gastric (OG) (in addition to core pathology) (One Occurrence per Path Report) | ||||||
Pathology Investigation Type * |
The type of pathology
investigation procedure carried out |
Code List |
CY |
Cytology |
R |
Pathology Investigation Type (pCR0760) |
BU |
Biopsy | |||||
EX |
Excision | |||||
PE |
Partial Excision | |||||
RE |
Radical Excision | |||||
FE |
Further Excision | |||||
CU |
Curettage | |||||
SB |
Shave Biopsy | |||||
PB |
Punch Biopsy | |||||
IB |
Incisional Biopsy | |||||
99 |
Uncertain/Other | |||||
FR |
Fresh - Upper GI | |||||
FF |
Formulin Fixed - Upper GI | |||||
Excision Margin (Proximal) |
Identify whether the
proximal margin is involved. |
Code List |
0 |
Margin not involved |
R |
Excision Margin (Proximal, Distal) (pUG14480) |
1 |
Margin involved | |||||
9 |
Not Known | |||||
Excision Margin (Distal) |
Identify whether the distal
margin is involved. |
Code List |
0 |
Margin not involved |
R |
Excision Margin (Proximal, Distal) (pUG14480) |
1 |
Margin involved | |||||
9 |
Not Known | |||||
Excision Margin (Circumferential) |
Identify whether
circumferential margin is involved. |
Code List |
0 |
Margin not involved |
R |
Excision Margin (Circumferential) (pUG14490) |
1 |
Margin involved | |||||
9 |
Not Known | |||||
Biomarkers - Oesophago-gastric (OG) | ||||||
HER2 Status |
To record the HER2 Status
for the patient, at diagnosis |
Code List |
1 |
Positive |
R |
N/A |
2 |
Negative | |||||
3 |
Not done | |||||
9 |
Not known | |||||
Dihydropyrimidine Dehydrogenase (DPD) Status |
To record the DPD Status for
the patient, if performed |
Code List |
1 |
DPYP variant homozygous |
R |
N/A |
2 |
DPYP variant heterozygous | |||||
3 |
No variant detected | |||||
9 |
Not known (Not Performed) | |||||
Oncology - Radiotherapy Details - Oesophago-gastric (OG) | ||||||
Start Date of Radiotherapy |
The date that the first cycle of radiotherapy was started |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Outcome of Radiotherapy |
Specify if the patient completed their treatment as prescribed |
Code List |
1 |
Treatment Completed as Prescribed |
R |
N/A |
2 |
Treatment Not completed | |||||
9 |
Not known (outcome) | |||||
Reason for Incomplete Radiotherapy |
Specify the reason if Radiotherapy was not completed |
Code List |
1 |
Patient died |
R |
N/A |
2 |
Progressive disease during radiotherapy | |||||
3 |
Toxicity | |||||
4 |
Patient choice (stopped or interrupted treatment) | |||||
7 |
Other | |||||
9 |
Not known (reason) | |||||
Oncology - Chemotherapy Details - Oesophago-gastric (OG) | ||||||
Chemotherapy Start Date |
The date that the first cycle of chemotherapy was started |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Outcome of Chemotherapy |
Specify if the patient completed their treatment as prescribed |
Code List |
1 |
Treatment Completed as Prescribed |
R |
N/A |
2 |
Treatment Not completed | |||||
9 |
Not known (outcome) | |||||
Reason for Incomplete Chemotherapy |
Specify the reason if Chemotherapy was not completed |
Code List |
1 |
Patient died |
R |
N/A |
2 |
Progressive disease during radiotherapy | |||||
3 |
Toxicity | |||||
4 |
Patient choice (stopped or interrupted treatment) | |||||
7 |
Other | |||||
9 |
Not known (reason) | |||||
Proceeded to Planned Curative Surgery |
Record if the patient
proceeded to curative surgery after neoadjuvant
chemotherapy |
Code List |
Y |
Yes |
D |
N/A |
N |
No | |||||
8 |
Not applicable | |||||
Oncology - Immunotherapy - Oesophago-gastric (OG) | ||||||
Start Date of Immunotherapy |
The date that the first cycle of immunotherapy was started |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Outcome of Immunotherapy |
Specify if the patient completed their treatment as prescribed |
Code List |
1 |
Treatment Completed as Prescribed |
R |
N/A |
2 |
Treatment Not completed | |||||
9 |
Not known (outcome) | |||||
Reason for Incomplete Immunotherapy |
Specify the reason if Immunotherapy was not completed |
Code List |
1 |
Patient died |
R |
N/A |
2 |
Progressive disease during radiotherapy | |||||
3 |
Toxicity | |||||
4 |
Patient choice (stopped or interrupted treatment) | |||||
7 |
Other | |||||
9 |
Not known (reason) |
National Cancer Data Standards for Wales – Upper Gastrointestinal (GI): Liver
Reporting Data Item |
Definition |
Format |
Code List (Code) |
Code List (Text) |
Status |
COSD |
Diagnosis - Liver - Core. To record diagnostic details for Liver Hepatocellular Carcinoma (HCC) & Cholangiocarcinoma (CC) (One Occurrence per core diagnosis group) | ||||||
Liver Surveillance Scans |
Record if the patient was receiving liver cancer surveillance scans? |
Code List |
Y |
Yes |
R |
Liver Surveillance Scans (LV16000) |
N |
No | |||||
9 |
Not Known | |||||
Liver Cirrhosis Type |
Record the type of liver cirrhosis |
Code List |
1 |
Compensated |
R |
Liver Cirrhosis Type (LV16010) |
2 |
Decompensated | |||||
8 |
Patient does not have cirrhosis of the liver | |||||
9 |
Not Known | |||||
Cause of Liver Cirrhosis |
Is the patient's liver
cirrhosis caused by known risk factors for liver disease?
|
Code List |
01 |
Alcohol excess |
R |
Cause of Liver Cirrhosis (LV16020) |
02 |
Hepatitis B virus infection | |||||
03 |
Hepatitis C virus infection | |||||
04 |
Non-alcohol related fatty liver disease | |||||
05 |
Hereditary haemochromatosis | |||||
06 |
Autoimmune hepatitis | |||||
07 |
Primary sclerosing cholangitis | |||||
10 |
Primary biliary cholangitis | |||||
98 |
Other | |||||
99 |
Not Known | |||||
Transplantation - Liver (for all types HCC, CC, Mets). To record liver transplantation details for the patient | ||||||
Liver Transplantation |
Was the patient listed for transplantation? |
Code List |
Y |
Yes |
R |
Liver Transplantation (LV16200) |
N |
No | |||||
9 |
Not known | |||||
Surgery - Liver (for all types HCC, CC, Mets) To record surgery details for Liver (One occurrence per core surgery) | ||||||
Surgery Type |
What type of liver surgery was performed? |
Code List |
1 |
Liver Resection |
R |
Surgery Type (LV16210) |
2 |
Liver Transplantation | |||||
Surgery - Liver - Core. To record further surgical details for all Liver (HCC,CC,Liver Mets) (One occurrence per Core group) | ||||||
Clavien-Dindo Classification of Surgical Classifications |
Record the overall grade as per the Clavien-Dindo Classification of Surgical Classifications |
Code List |
1 |
Grade I |
R |
Clavien-Dindo Classification of Surgical Classifications (UG15060) |
2 |
Grade II | |||||
3 |
Grade IIIa | |||||
4 |
Grade IIIb | |||||
5 |
Grade IVa | |||||
6 |
Grade IVb | |||||
7 |
Grade V | |||||
9 |
Not known (not recorded) | |||||
Treatment & Prognostic Indicators - Liver - Core. To record further staging details for Liver HCC & CC (One occurrence per Core Treatment group) | ||||||
Portal Invasion |
Record whether there is tumour present in the main portal vein, or if there is tumour present in a branch of the portal vein or if there is no tumour present in the portal vein. |
Code List |
1 |
Branch |
R |
Portal Invasion (LV16120) |
2 |
Main | |||||
3 |
Not Present | |||||
9 |
Not known | |||||
Liver - Hepatocellular Carcinoma (HCC). Record additional data items for all HCC Malignancies | ||||||
Staging Details - Liver - HCC | ||||||
Number of Liver Lesions Seen |
Total number of liver lesions seen on imaging |
max n2 |
N/A |
N/A |
M |
N/A |
Size of Largest Liver Lesion |
Record the size of the largest liver lesion seen on imaging |
max n2 |
N/A |
N/A |
M |
N/A |
Vascular Invasion |
Record if vascular invasion is present or absent |
Code List |
Y |
Present |
M |
N/A |
N |
Not present | |||||
9 |
Not Known | |||||
Chronic Liver Disease |
Record if chronic liver disease is present or absent |
Code List |
Y |
Present |
M |
N/A |
N |
Not present | |||||
9 |
Not Known | |||||
Cause of Chronic Liver Disease |
Is the patient's cause of
chronic liver disease caused by known risk factors?
|
Code List |
01 |
Alcohol excess |
M |
N/A |
02 |
Hepatitis B virus infection | |||||
03 |
Hepatitis C virus infection | |||||
04 |
Non-alcohol related fatty liver disease | |||||
05 |
Hereditary haemochromatosis | |||||
06 |
Autoimmune hepatitis | |||||
07 |
Primary sclerosing cholangitis | |||||
10 |
Primary biliary cholangitis | |||||
98 |
Other | |||||
99 |
Not Known | |||||
Child-Pugh Score |
Record the overall Child-Pugh score. This is the level of disease of the liver. |
Code List |
A |
Child-Pugh A |
M |
Child-Pugh Score (LV16140) |
B |
Child-Pugh B | |||||
C |
Child-Pugh C | |||||
Alpha Fetoprotein (Serum) |
Maximum Serum level of alpha
feto protein at diagnosis. AFP units recorded in kU/l
|
max n6 |
N/A |
N/A |
M |
Alpha Fetoprotein (Serum) (CR8920) |
CT or MRI - full information recorded |
Specify if patient's CT or
MRI report contains the specified full information required to enable the
correct management decisions to be made at the MDT |
Code List |
Y |
Yes |
D |
N/A |
N |
No | |||||
9 |
No CT or MRI done | |||||
Site Specific Staging - Liver - HCC. To record site specific staging details (One occurrence per Core Staging group) | ||||||
Barcelona Clinic Liver Cancer (BCLC) Stage |
The Barcelona Clinic Liver Cancer (BCLC) stage, includes both anatomic and non-anatomic factors and is widely used within the UK to predict prognosis and determine treatment. |
Code List |
0 |
Very early |
M |
Barcelona Clinic Liver Cancer (BCLC) Stage (LV16100) |
A |
Early | |||||
B |
Intermediate | |||||
C |
Advanced | |||||
D |
Terminal | |||||
Pathology - Liver. To record additional pathology details for Liver, HCC (One occurrence per pathology) | ||||||
Number of Tumours Present |
Specify the number of tumours present |
max n2 |
N/A |
N/A |
R |
N/A |
Bile Duct Invasion |
An indication of whether bile duct invasion was present or absent |
Code List |
Y |
Yes - Present |
R |
N/A |
N |
No - Not Present | |||||
Type of Fibrosis/Cirrhosis in background liver |
Specify the type of fibrosis Fibrosis/Cirrhosis in Background Liver |
Code List |
1 |
Not Bridging |
R |
N/A |
2 |
Bridging | |||||
3 |
Bridging with nodules | |||||
4 |
Complete Cirrhosis | |||||
0 |
None present | |||||
Treatment - Liver. To record other procedure details Liver - HCC (One occurrence per Core Treatment group) | ||||||
Ablative Therapy Type |
Describe type of ablative (ie locally destructive treatment) therapy used if any. |
Code List |
R |
Radiofrequency ablation |
R |
Ablative Therapy Type (LV16300) |
M |
Microwave ablation | |||||
8 |
Other ablative treatment | |||||
9 |
Not Known | |||||
Embolisation Modality |
What modality of the Liver
Trans Arterial Embolisation was used? |
Code List |
1 |
TAE/BLAND |
R |
Embolisation Modality (LV16320) |
2 |
C-TACE | |||||
3 |
DEB-TACE | |||||
4 |
RO DEB-TACE | |||||
5 |
SIRT | |||||
9 |
Not known | |||||
Treatment & Prognostic Indicators - Liver - HCC (One occurrence per Core Treatment group) | ||||||
Child-Pugh Score |
Record the overall Child-Pugh score. This is the level of disease of the liver. |
Code List |
A |
Child-Pugh A |
R |
Child-Pugh Score (LV16140) |
B |
Child-Pugh B | |||||
C |
Child-Pugh C | |||||
UKELD Score |
Record the UKELD score. The
UKELD score is calculated using bilirubin, INR, creatine and sodium. It
predicts the risk of mortality due to liver cirrhosis and is used to
assess need for liver transplantation. |
max n2 |
N/A |
N/A |
R |
UKELD Score (LV16130) |
Liver - Cholangiocarcinoma (CC). Record for all Cholangiocarcinoma (CC) Malignancies | ||||||
Diagnosis - Cholangiocarcinoma. To record diagnostic details for Cholangiocarcinoma (One occurrence per core diagnosis group) | ||||||
Cholangiocarcinoma Category |
State where the
Cholangiocarcinoma is present, using the designated categories. Any
cholangiocarcinoma which involves the anatomical hilum of the liver must
be classified as perihilar |
Code List |
1 |
Intrahepatic |
M |
Cholangiocarcinoma Category (LV16400) |
2 |
Perihilar | |||||
3 |
Extrahepatic | |||||
4 |
Distal | |||||
Preoperative Drainage Type |
Specify the pre-operative
drainage type |
Code List |
1 |
PTC (Percutaneous Transhepatic Cholangiogram) |
R |
N/A |
2 |
ERCP (Endoscopic Retrograde Cholangiopancreatography) | |||||
3 |
No drainage required | |||||
Treatment - Liver - CC (One occurrence per Core Treatment group) | ||||||
Date of Referral for Palliative Chemotherapy |
Specify the date the referral was made for palliative chemotherapy |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Liver - Liver Metastases.
To be recorded for all types of Pathways - Primary progression/Non
Primary Pathway - Progression & Recurrence. | ||||||
Treatment - Liver Metastases. To record other procedure details Liver Mets (One occurrence per Core Treatment group) | ||||||
Ablative Therapy Type |
Describe type of ablative (ie locally destructive treatment) therapy used if any. |
Code List |
R |
Radiofrequency ablation |
R |
Ablative Therapy Type (LV16300) |
M |
Microwave ablation | |||||
8 |
Other ablative treatment | |||||
9 |
Not Known | |||||
Embolisation Modality |
What modality of the Liver
Trans Arterial Embolisation was used? |
Code List |
1 |
TAE/BLAND |
R |
Embolisation Modality (LV16320) |
2 |
C-TACE | |||||
3 |
DEB-TACE | |||||
4 |
RO DEB-TACE | |||||
5 |
SIRT | |||||
9 |
Not known | |||||
Pathology - Liver Metastases. To record additional pathology details for Liver Mets (One occurrence per core surgery) | ||||||
Total Number of Colorectal Metastases in Liver Code |
Record the total number of colorectal metastases identified in the resected liver |
max n2 |
N/A |
N/A |
R |
Total Number of Colorectal Metastases in Liver Code (pUG14500) |
Number of Tumours Present |
Specify the number of tumours present |
max n2 |
N/A |
N/A |
R |
N/A |
Bile Duct Invasion |
An indication of whether bile duct invasion was present or absent |
Code List |
Y |
Yes - Present |
R |
N/A |
National Cancer Data Standards for Wales – Upper Gastrointestinal (GI): Gastrointestinal Stromal Tumour (GIST)
Reporting Data Item |
Definition |
Format |
Code List (Code) |
Code List (Text) |
Status |
COSD |
Surgery - GIST. To record additional surgery details for GIST tumours (One occurrence per surgery) | ||||||
Tumour Rupture |
Record if the tumour ruptured at the time of surgery |
Code List |
Y |
Yes |
R |
N/A |
N |
No | |||||
Pathology - GIST. To record additional pathology details for GIST tumours (One occurrence per pathology) | ||||||
Mitotic Count |
Record the mitotic count per 5mm² |
max n2 |
|
|
R |
N/A |
Tumour Rupture (Pathology) |
Record if the tumour ruptured at the time of surgery as seen within sample |
Code List |
Y |
Yes |
R |
N/A |
N |
No | |||||
Molecular & Biomarkers - GIST. To record additional Molecular & Biomarker details for GIST tumours | ||||||
Date Referred for Mutational Analysis |
Record the date the patient was referred for mutational analysis |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Wild Type |
Specify if the marker tested resulted in a mutation |
Code List |
1 |
Mutation detected |
R |
N/A |
2 |
No mutation detected | |||||
3 |
No Mutational Analysis Performed | |||||
Prognostic Index - GIST. To record Prognostic details for GIST tumours | ||||||
Risk Recurrence Score |
Record the associated risk recurrence score |
Code List |
0 |
No Risk |
R |
N/A |
1 |
Very Low Risk | |||||
2 |
Low Risk | |||||
3 |
Moderate Risk | |||||
4 |
High Risk |
National Cancer Data Standards for Wales – Upper Gastrointestinal (GI): Neuroendocrine Tumour (NET)
Reporting Data Item |
Definition |
Format |
Code List (Code) |
Code List (Text) |
Status |
COSD |
Diagnosis | ||||||
NET Primary Site Code
|
The NET primary site SNOMED
code as defined by the Specialist |
min n6 max n18 |
N/A |
N/A |
M |
N/A |
NET Primary Site Code Description (SNOMED) |
The NET primary site SNOMED
description of code as defined by the Specialist |
max an100 |
N/A |
N/A |
D |
N/A |
Key Investigations | ||||||
Functioning Status (Syndrome) |
A record of the functioning status for the patient (at diagnosis) |
Code List |
Y |
Yes - Patient has 'carcinoid syndrome'/patient has a functioning tumour |
R |
N/A |
N |
No - Patient has a non-functioning tumour | |||||
8 |
Not applicable | |||||
9 |
Not recorded | |||||
Gut Hormone Profile |
The result of gut hormone profile blood test |
Code List |
1 |
Abnormal |
R |
N/A |
2 |
Normal | |||||
3 |
Not done | |||||
4 |
Patient refused | |||||
8 |
Not applicable | |||||
9 |
Not recorded | |||||
Gut Hormone Profile Type |
Specify the type found
within the gut hormone profile (at diagnosis) |
Code List |
1 |
Insulin |
R |
N/A |
2 |
Gastrin | |||||
3 |
Glucagon | |||||
4 |
VIP (Vasoactive Intestinal Peptide) | |||||
5 |
Somatostatin | |||||
8 |
Not applicable | |||||
9 |
Not recorded | |||||
5-HIAA Test |
The result of 24 hour 5
hydoxyindole acetic acid (5-HIAA) urine test |
Code List |
1 |
Abnormal (High) |
R |
N/A |
2 |
Normal | |||||
3 |
Not done | |||||
4 |
Patient refused | |||||
8 |
Not Applicable | |||||
9 |
Not recorded | |||||
Chromogranin (CgA) Value |
Specify the absolute value of the Chromogranin test (at diagnosis). |
Integer n3 |
N/A |
N/A |
M |
N/A |
Chromogranin A (CgA) Test Result |
The result of the
Chromogranin A blood test |
Code List |
1 |
Abnormal (High) |
D |
N/A |
2 |
Normal | |||||
3 |
Not done | |||||
4 |
Patient refused | |||||
8 |
Not Applicable | |||||
9 |
Not recorded | |||||
Serotonin Test |
The result of the Serotonin blood test |
Code List |
1 |
Abnormal (High) |
R |
N/A |
2 |
Normal | |||||
3 |
Not done | |||||
4 |
Patient refused | |||||
8 |
Not Applicable | |||||
9 |
Not recorded | |||||
Key Imaging | ||||||
Date of Somatostatin Receptor Imaging (Octreoscan) |
The date somatostatin
receptor imaging (octreotide scan/octreoscan) was completed as part of
NETs diagnostic work-up |
ccyymmdd |
N/A |
N/A |
D |
N/A |
Date of MRI |
The date MRI imaging was
completed as part of NETs diagnostic work-up |
ccyymmdd |
N/A |
N/A |
D |
N/A |
Date of CT |
The date CT Imaging was
completed as part of NETs diagnostic work-up |
ccyymmdd |
N/A |
N/A |
D |
N/A |
Date of FDG PET CT |
The date FDG PET CT imaging
was completed as apart of NETs diagnostic work-up |
ccyymmdd |
N/A |
N/A |
D |
N/A |
Date of Gallium 68 PET |
The date Gallium68 PET
Imaging was completed as part of NETs diagnostic work up |
ccyymmdd |
N/A |
N/A |
D |
N/A |
Surgery | ||||||
Clavien-Dindo Classification of Surgical Classifications |
Record the overall grade as per the Clavien-Dindo Classification of Surgical Classifications |
Code List |
1 |
Grade I |
R |
Clavien-Dindo Classification of Surgical Classifications (UG15060) |
2 |
Grade II | |||||
3 |
Grade IIIa | |||||
4 |
Grade IIIb | |||||
5 |
Grade IVa | |||||
6 |
Grade IVb | |||||
7 |
Grade V | |||||
9 |
Not known (not recorded) | |||||
Pathology | ||||||
Histological Type and Grade |
Specify the histological type and grade of the NET resection |
Code List |
01 |
Well-differentiated, NET G1 (M8240/3) |
R |
N/A |
02 |
Well-differentiated, NET G2 | |||||
03 |
Well-differentiated, NET G3 | |||||
04 |
Well-differentiated, grade cannot be assessed | |||||
05 |
Poorly differentiated NEC G3, small cell | |||||
06 |
Poorly differentiated NEC G3, large cell | |||||
07 |
Poorly differentiated NEC, NOS | |||||
08 |
Mixed NE-non NE
carcinoma/MiNEN | |||||
09 |
Gangliocytic paraganglioma (for duodenal/ampullary/proximal jejunal/pancreatic NET resections) | |||||
97 |
Other | |||||
Proliferation Index with Ki-67 |
Record the Proliferation Index with Ki-67 |
Code List |
1 |
Low (<6%) |
R |
N/A |
2 |
Intermediate (6-10%) | |||||
3 |
High (>10%) | |||||
Mitotic Count |
Record the Mitotic count |
Integer |
N/A |
N/A |
R |
N/A |
Presence of Necrosis |
Record whether there is presence of necrosis |
Code List |
1 |
Present |
R |
N/A |
2 |
Not Identified | |||||
Perineural Invasion |
A record to determine whether there was perineural invasion noted after pathological reporting of tumour sample. |
Code List |
Y |
Yes (Perineural invasion present) |
R |
N/A |
N |
No (Perineural invasion not present) | |||||
8 |
Not applicable (Not sampled) | |||||
9 |
Not recorded (not recorded in pathology report) | |||||
Immunohistochemistry - Chromogranin |
A record to determine whether chromogranin immunohistochemistry (IHC) stain was carried out on tumour sample |
Code List |
1 |
Positive |
R |
N/A |
2 |
Negative | |||||
3 |
Equivocal | |||||
4 |
Insufficient material | |||||
5 |
Not done (No surgery/biopsy) | |||||
9 |
Not recorded (not recorded in pathology report) | |||||
Immunohistochemistry - Synaptophysin |
A record to determine whether synaptophysin Immunohistochemistry (IHC) stain was carried out on tumour sample |
Code List |
1 |
Positive |
R |
N/A |
2 |
Negative | |||||
3 |
Equivocal | |||||
4 |
Insufficient material | |||||
5 |
Not done (No surgery/biopsy) | |||||
9 |
Not recorded (not recorded in pathology report) | |||||
Immunohistochemistry - CD56 |
A record to determine whether CD56 immunohistochemistry (IHC) stain was carried out on tumour sample |
Code List |
1 |
Positive |
R |
N/A |
2 |
Negative | |||||
3 |
Equivocal | |||||
4 |
Insufficient material | |||||
5 |
Not done (No surgery/biopsy) | |||||
9 |
Not recorded (not recorded in pathology report) | |||||
Pathology - For Gastric NETs | ||||||
Gastric NET Type |
Specify the type of Gastric NET |
Code List |
1 |
Type I |
R |
N/A |
2 |
Type II | |||||
3 |
Type III | |||||
9 |
Cannot Be Assessed | |||||
MDT Details | ||||||
MDT Decision * |
This denotes the decision
the MDT took on the management of the patients care |
Code List |
01 |
Surgery |
R |
Planned Cancer Treatment Type (CR0470) |
03 |
Chemotherapy | |||||
07 |
Biological Therapy | |||||
19 |
Transartierial (Chemo)-embolisation (TACE) | |||||
20 |
Radiofrequency Ablation (RFA) | |||||
21 |
Radionuclide Treatment | |||||
22 |
Further Imaging/ Diagnostic Tests | |||||
23 |
Somatostatin Analogues (SSAs) | |||||
24 |
No further treatment/follow up required | |||||
25 |
Follow up only | |||||
26 |
Supportive Care Only | |||||
98 |
Not applicable | |||||
99 |
Not Recorded/Not Known | |||||
Treatments | ||||||
Type of First Cancer
|
This denotes the first
specific treatment modality administered to a patient |
Code List |
01 |
Surgery |
R |
Planned Cancer Treatment Type (CR0470) |
05 |
Teletherapy (Beam Radiation excluding Proton Therapy) | |||||
08 |
Active Monitoring | |||||
02 |
Anti-Cancer Drug Regimen (Cytotoxic Chemotherapy) | |||||
21 |
Biological Therapies (excluding Immunotherapy) | |||||
15 |
Anti-Cancer Drug Regimen (Immunotherapy) | |||||
10 |
Radiofrequency ablation (RFA) | |||||
12 |
Cryotherapy | |||||
24 |
Transartierial (Chemo)-embolisation (TACE) | |||||
25 |
Radionuclide Treatment | |||||
26 |
Somatostatin analogues (SSA) | |||||
27 |
Supportive Care Only | |||||
97 |
Other Therapy/Other Treatment | |||||
96 |
Patient died before treatment | |||||
98 |
Patient refused all therapies/All treatment declined | |||||
99 |
Not Recorded | |||||
Date of First Cancer Treatment |
This denotes the date the
Type of First Cancer Treatment was given to the patient
|
ccyymmdd |
N/A |
N/A |
D |
N/A |
Liver Ablative Therapy |
A record of whether liver ablative therapy was performed |
Code List |
1 |
Microwave ablation |
R |
N/A |
2 |
Radiofrequency ablation (RFA) | |||||
3 |
Patient died before treatment | |||||
4 |
Patient refused treatment | |||||
8 |
Not applicable | |||||
9 |
Not recorded | |||||
Liver Ablative Therapy Date |
This denotes the date on
which liver ablative therapy was performed |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Embolisation Therapy |
This denotes if the patient had transarterial chemoembolisation (TACE), transarterial embolisation (TAE) or selective internal radiation therapy (SIRT) treatment |
Code List |
1 |
TACE (Transarterial chemoembolisation) |
R |
N/A |
2 |
TAE (Transarterial embolisation) | |||||
3 |
SIRT (Selective internal radiation therapy) | |||||
4 |
Patient died before embolisation therapy | |||||
5 |
Patient refused embolisation therapy | |||||
8 |
Not Applicable (no embolisation therapy given) | |||||
9 |
Not Recorded | |||||
Embolisation Therapy Date (TACE/TAE/SIRT) |
This denotes the date on
which chemoemolisation (TACE), TAE or SIRT was performed |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Peptide Receptor Nuclide Therapy (PRRT) Type |
This denotes the type of peptide receptor nuclide therapy (PRRT) |
Code List |
01 |
MIBG (Metaiodobenzylguanidine) |
R |
N/A |
02 |
Lutetium 177 (LU 177/Lutathera) | |||||
03 |
Yttrium 90 (YU 90) | |||||
04 |
Patient died before PRRT | |||||
05 |
Patient refused PRRT | |||||
98 |
Not applicable (no PRRT given) | |||||
97 |
Other | |||||
99 |
Not recorded | |||||
Peptide Receptor Nuclide Therapy (PRRT) Type - Other |
Where Peptide Receptor Nuclide Therapy (PRRT) Type is recorded as Other, please specify the type |
max an50 |
N/A |
N/A |
R |
N/A |
Peptide Receptor Nuclide Therapy (PRRT) - Start Date |
This denotes the date on
which peptide receptor nuclide therapy (PRRT) was commenced
|
ccyymmdd |
N/A |
N/A |
R |
N/A |
Peptide Receptor Nuclide Therapy (PRRT) - End Date |
This denotes the date on
which peptide receptor nuclide therapy (PRRT) was
completed |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Bassi Classification |
Morbidity and mortality after pancreatic surgery as recorded using the Bassi Classification. |
Code List |
01 |
A - Any definition from the normal po-operative course without pharmacologic treatment or surgical, endoscopic and radiological interventions. Allowed therapeutic regimens are drugs such as antiemetics, antipyretics, analgesics, diuretics, electrolytes and physiotherapy. This grade also includes wound infections opened at the bed side |
R |
N/A |
02 |
B - Requiring pharmacologic treatment with drugs other than ones allowed for grade A complications. Blood transfusion and total parental nutrition are also included C-Ca-Cb | |||||
03 |
C - Requiring surgical, endoscopic or radiology intervention | |||||
04 |
C(a) - Intervention not under general anaesthesia | |||||
05 |
C(b) - Intervention under general anaesthesia | |||||
06 |
D - Life threatening complication requiring intermediate care/intensive care unit management | |||||
07 |
D(a) - Single organ dysfunction | |||||
08 |
D(b) - Multi organ dysfunction | |||||
09 |
E - Death of a patient | |||||
10 |
Suffix ‘d’- If the patient suffers from complication at the time of discharge, the suffix 'd' (for disability) is added to the respective grade of complication | |||||
98 |
Not applicable | |||||
99 |
Not recorded |
National Cancer Data Standards for Wales – Upper Gastrointestinal (GI): Pancreas
Reporting Data Item |
Definition |
Format |
Code List (Code) |
Code List (Text) |
Status |
COSD |
Surgery - Pancreatic (One occurrence per Core Surgery) | ||||||
Clavien-Dindo Classification of Surgical Classifications |
Record the overall grade as per the Clavien-Dindo Classification of Surgical Classifications |
Code List |
1 |
Grade I |
R |
Clavien-Dindo Classification of Surgical Classifications (UG15060) |
2 |
Grade II | |||||
3 |
Grade IIIa | |||||
4 |
Grade IIIb | |||||
5 |
Grade IVa | |||||
6 |
Grade IVb | |||||
7 |
Grade V | |||||
9 |
Not known (not recorded) | |||||
Vascular Resection |
Were vessels resected to ensure tumour margins
negative? |
Code List |
0 |
No vascular resection |
R |
N/A |
1 |
Partial portal vein/SMV resection (cuff) | |||||
2 |
Circumferential portal vein/SMV resection | |||||
3 |
Arterial resection | |||||
4 |
IVC resection | |||||
Splenic Resection |
Was the spleen removed during the Procedure? |
Code List |
0 |
No Splenectomy |
R |
N/A |
1 |
Planned Splenectomy | |||||
2 |
Unplanned Splenectomy for Oncological Reasons | |||||
3 |
Unplanned Splenectomy for Non-Oncological Reasons | |||||
Surgical Palliation Type |
Type of surgical palliation performed if any e.g., Hepaticojejunostomy |
Code List |
0 |
None |
R |
Surgical Palliation Type (UG13240) |
1 |
Gastric bypass | |||||
2 |
Biliary bypass | |||||
3 |
Gastric/biliary bypass | |||||
4 |
Celiac plexus block | |||||
9 |
Not Known | |||||
Pre-Operative Stenting |
Did the patient have a biliary stent placed prior to surgery? |
Code List |
0 |
None |
R |
N/A |
1 |
Plastic | |||||
2 |
Metal covered | |||||
3 |
Metal uncovered | |||||
Surgery - Pancreas - Endocsopic or Radiological Procedures (One occurrence per Core Surgery) | ||||||
Endoscopic Procedure Type |
The main endoscopic
procedures carried out. |
Code List |
1 |
Stent insertion |
R |
Endoscopic Procedure Type (UG14290) |
4 |
Photodynamic therapy | |||||
8 |
Other | |||||
Endoscopic or Radiological Complication Type |
The types of complications
that the patient experiences during the admission for the endoscopic
procedure. |
Code List |
00 |
No complications |
R |
Endoscopic or Radiological Complication Type (UG13090) |
02 |
Perforation | |||||
03 |
Haemorrhage | |||||
09 |
Pancreatitis | |||||
10 |
Cholangitis | |||||
88 |
Other | |||||
Cancer Care Plan - Pancreas. To carry details of the cancer care plan for Pancreas (One occurrence of this group) | ||||||
Resectability Based on Radiology |
Record the MDT opinion of tumour resectability |
Code List |
1 |
Resectable |
R |
N/A |
2 |
Borderline | |||||
3 |
Locally Advanced | |||||
4 |
Unresectable due to Metastatic Disease | |||||
Tumour Markers |
CA19-9 and Chromogranins A +
B |
Code List |
1 |
Ca 19-9 Value |
R |
N/A |
2 |
Chromogranin A Value | |||||
3 |
Chromogranin B Value | |||||
Pathology - Pancreas. To record additional pathology details for Pancreas tumours (One occurrence per pathology) | ||||||
Neurovascular Invasion |
Is there evidence of neurovascular invasion in the resected specimen |
Code List |
1 |
Present |
R |
N/A |
2 |
Not Present | |||||
Resection Margin Status |
Is there evidence of margin involvement? |
Code List |
1 |
Tumour >1mm from resection margins |
R |
N/A |
2 |
Tumour <1mm from resection margin | |||||
3 |
Tumour present at resection margin | |||||
4 |
Margins grossly involved | |||||
Margins Involved |
Specify which margins are
involved? |
Code List |
01 |
Anterior pancreatic surface |
R |
N/A |
|
|
|
02 |
SMA dissection margin |
|
|
|
|
|
03 |
SMV dissection margin |
|
|
|
|
|
04 |
Proximal enteric transection margin |
|
|
|
|
|
05 |
Distal duodenal transection margin |
|
|
|
|
|
06 |
Pancreatic transection margin |
|
|
|
|
|
07 |
Bile duct transection margin |
|
|
|
|
|
08 |
Posterior dissection margin |
|
|
National Cancer Data Standards for Wales – Upper Gastrointestinal (GI): High Grade Dysplasia
Reporting Data Item |
Definition |
Format |
Code List (Code) |
Code List (Text) |
Status |
COSD |
Record HGD data
collection for the following where: | ||||||
Referral - High Grade Dysplasia (HGD). To carry referral details for OG (One occurrence of this group) | ||||||
Source of Referral for Out-patients (CWT) * |
The source of referral
classification used to identify the source of referral of each episode or
referral |
Code List |
02 |
Symptomatic |
M |
Source of Referral for Out-patients (CWT) (CR1600) |
21 |
From Barrett's Surveillance | |||||
99 |
Not Known | |||||
Diagnosis - High Grade Dysplasia (HGD). To carry additional diagnosis details for HGD Surgical Palliation Type (One occurrence of this group) | ||||||
Original Diagnosis of HGD confirmed by a second pathologist |
To indicate if the original
diagnosis of HGD was confirmed by a second pathologist. |
Code List |
Y |
Yes |
M |
N/A |
N |
No | |||||
9 |
Not Known | |||||
Comorbidity |
Specify what other long term
conditions the patient has at diagnosis. To detail the
nature of any pre-existing conditions/co-morbidity which may have an
effect on subsequent treatment. |
Code List |
00 |
None |
R |
N/A |
01 |
COPD/Asthma | |||||
02 |
Chronic Renal Impairment | |||||
03 |
Liver Failure or Cirrhosis | |||||
04 |
Diabetes | |||||
05 |
Mental Illness | |||||
07 |
Ischemic Heart Disease | |||||
08 |
Cerebrovascular Disease | |||||
09 |
Peripheral Vascular Disease | |||||
97 |
Significant Other | |||||
Barrett's Segment Involved |
To indicate if Barrett’s
segment is involved. |
Code List |
1 |
Present |
R |
N/A |
2 |
Absent | |||||
9 |
Not Known | |||||
Lesion of Glandular or Squamous Mucosa |
To indicate if the lesion at
diagnosis is of glandular or squamous mucosa. |
Code List |
1 |
Glandular |
R |
N/A |
2 |
Squamous Mucosa | |||||
9 |
Not Known | |||||
Appearance of HGD |
Describe the HGD appearance.
|
Code List |
1 |
Flat mucosa |
R |
N/A |
2 |
Nodular lesion | |||||
3 |
Depressed lesion | |||||
4 |
Ulcerated | |||||
9 |
Not Known | |||||
Length (cm) |
Record the specific
Barrett’s segment length (cm) |
max
n2 |
N/A |
N/A |
R |
N/A |
Circumferential Segment |
As part of the Prague
Classification, record the circumferential segment - C in
cm |
max
n2 |
N/A |
N/A |
R |
N/A |
Maximum Barrett’s Extent |
As part of the Prague
Classification, record the maximum Barrett’s extent - M in
cm |
max
n2 |
N/A |
N/A |
R |
N/A |
Cancer Care Plan - High Grade Dysplasia (HGD). To carry additional details of the cancer care plan for HGD (One occurrence of this group) | ||||||
Planned Cancer Treatment
|
This is the clinically
proposed treatment, |
Code List |
01 |
Surgery |
R |
Planned Cancer Treatment Type (CR0470) |
27 |
Surveillance (follow up endoscopy) | |||||
28 |
No surveillance or endoscopy | |||||
10 |
Other Active Treatment | |||||
Reason for the Treatment Plan |
Indicate what was the reason
for the treatment plan. |
Code List |
1 |
Patient choice |
R |
N/A |
2 |
Patient unfit for endoscopic or surgical treatment | |||||
3 |
Lack of access to endoscopic treatment or surgery | |||||
9 |
Not Known | |||||
If plan was Surveillance, when is next surveillance endoscopy planned |
Indicate when the next
surveillance endoscopy is planned for. |
Code List |
1 |
3 months or less |
R |
N/A |
2 |
4-6 months | |||||
3 |
7-12 months | |||||
4 |
More than 12 months | |||||
9 |
Not Known | |||||
Treatments - High Grade Dysplasia. Treatment Summary - to record HGD treatment details (Multiple occurrences of this group can be added) | ||||||
Initial Treatment Modality * |
Specify the initial
treatment modality. |
Code List |
01 |
Surgery |
R |
Cancer Treatment Modality (Registration) (CR2040) |
16 |
Light Therapy (including Photodynamic Therapy and Psoralen and Ultra Violet A (PUVA) Therapy | |||||
10 |
Radiofrequency ablation (RFA) | |||||
29 |
Argon plasma coagulation | |||||
30 |
Multipolar electrocautery | |||||
28 |
Laser Treatment (excluding Argon Beam therapy) | |||||
12 |
Cryotherapy | |||||
31 |
Endoscopic resection (including EMR and ESD) | |||||
97 |
Other Treatment | |||||
Secondary Treatment Modality/Modalities * |
Specify the secondary
treatment modality/modalities given. |
Code List |
01 |
Surgery |
R |
Cancer Treatment Modality (Registration) (CR2040) |
16 |
Light Therapy (including Photodynamic Therapy and Psoralen and Ultra Violet A (PUVA) Therapy | |||||
10 |
Radiofrequency ablation (RFA) | |||||
29 |
Argon plasma coagulation | |||||
30 |
Multipolar electrocautery | |||||
28 |
Laser Treatment (excluding Argon Beam therapy) | |||||
12 |
Cryotherapy | |||||
31 |
Endoscopic resection (including EMR and ESD) | |||||
04 |
Chemoradiotherapy | |||||
97 |
Other Treatment | |||||
Hospital where initial treatment was given |
The Organisation Identifier
of the Organisation/hospital where the initial treatment was given. |
min an5 |
N/A |
N/A |
R |
N/A |
Hospital/s where secondary treatment modality/modalities given |
The Organisation Identifier
of the Organisation/hospital where the initial treatment was given. |
min an5 |
N/A |
N/A |
R |
N/A |
Date initial treatment commenced |
The date that the initial
treatment commenced (was given). |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Pathology - For High Grade Dysplasia (One Occurrence per Path Report) | ||||||
EMR/ESD Date |
Record the date of most recent EMR |
ccyymmdd |
N/A |
N/A |
R |
N/A |
Involvement of Lateral Margins |
State the involvement of the
lateral resection margins. |
Code List |
1 |
Clear of HGD/Cancer |
R |
N/A |
2 |
Positive | |||||
9 |
Not Known | |||||
Involvement of Deep Margins |
State the involvement of the
deep resection margins. |
Code List |
1 |
Clear of HGD/Cancer |
R |
N/A |
2 |
Positive | |||||
9 |
Not Known | |||||
EMR Pathology |
Describes the results of the
EMR Pathology. |
Code List |
1 |
High grade dysplasia confirmed |
R |
N/A |
2 |
Intramucosal carcinoma identified | |||||
3 |
Submucosal carcinoma or worse | |||||
4 |
No dysplasia | |||||
5 |
Low grade dysplasia | |||||
What is the ongoing plan/further treatment after endoscopic resection |
Record what the ongoing plan/further treatment is required after endoscopic resection |
Code List |
1 |
Further endoscopic resection |
R |
N/A |
2 |
Further ablative endoscopic treatment | |||||
3 |
Refer for Oesophagectomy | |||||
4 |
Endoscopic surveillance only | |||||
5 |
No further surveillance or treatment | |||||
9 |
Not known |